Obsessive-compulsive disorder as a first manifestation of Ataxia with Oculomotor Apraxia type 2 due to a novel mutation of SETX gene.

AOA2 Ataxia Obsessive-compulsive disorder SETX Whole-exome sequencing

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
19 Sep 2024
Historique:
received: 10 06 2024
accepted: 02 09 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 18 9 2024
Statut: aheadofprint

Résumé

Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive disorder presenting with cerebellar ataxia, sensory-motor axonal neuropathy, oculomotor apraxia, cerebellar atrophy and high alpha-fetoprotein (AFP) serum level. AOA2 is due to coding mutations of the SETX gene, mapped to chromosome 9q34. Seldom noncoding mutations affecting RNA processing have been reported too. To date psychiatric symptoms have never been reported in AOA2. A 19 years-old man came to our attention for progressive gait ataxia debuted five years earlier. His past medical history was unremarkable, while his parents were consanguineous. On neurological examination, he had bilateral horizontal gaze-evoked nystagmus with hypometric saccades and saccadic horizontal smooth pursuit, appendicular ataxia, limbs and trunk myoclonic involuntary movements with hands' dystonic postures and dance of the tendons. Psychological evaluation described intrusive and obsessive thoughts experienced by the patient, then diagnosed as obsessive-compulsive disorder. Blood tests detected an elevated AFP level. Brain MRI showed cerebellar atrophy, while electroneuromyography revealed an axonal sensory-motor polyneuropathy. In the suspicion of a pathology belonging to the autosomal recessive cerebellar ataxias (ARCA) spectrum disorder, a direct search of point mutations by whole-exome sequencing was performed revealing a novel biallelic variant in SETX gene (c.6208+2dupT), which was classified as likely pathogenic. The present case expands the genotypic and phenotypic spectrum of AOA2, reporting a novel likely pathogenic SETX mutation (c.6208+2dupT) and highlighting an early psychiatric involvement in AOA2, suggesting the need for psychiatric assessment in these neurologic patients.

Sections du résumé

BACKGROUND BACKGROUND
Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive disorder presenting with cerebellar ataxia, sensory-motor axonal neuropathy, oculomotor apraxia, cerebellar atrophy and high alpha-fetoprotein (AFP) serum level. AOA2 is due to coding mutations of the SETX gene, mapped to chromosome 9q34. Seldom noncoding mutations affecting RNA processing have been reported too. To date psychiatric symptoms have never been reported in AOA2.
CASE PRESENTATION METHODS
A 19 years-old man came to our attention for progressive gait ataxia debuted five years earlier. His past medical history was unremarkable, while his parents were consanguineous. On neurological examination, he had bilateral horizontal gaze-evoked nystagmus with hypometric saccades and saccadic horizontal smooth pursuit, appendicular ataxia, limbs and trunk myoclonic involuntary movements with hands' dystonic postures and dance of the tendons. Psychological evaluation described intrusive and obsessive thoughts experienced by the patient, then diagnosed as obsessive-compulsive disorder. Blood tests detected an elevated AFP level. Brain MRI showed cerebellar atrophy, while electroneuromyography revealed an axonal sensory-motor polyneuropathy. In the suspicion of a pathology belonging to the autosomal recessive cerebellar ataxias (ARCA) spectrum disorder, a direct search of point mutations by whole-exome sequencing was performed revealing a novel biallelic variant in SETX gene (c.6208+2dupT), which was classified as likely pathogenic.
CONCLUSION CONCLUSIONS
The present case expands the genotypic and phenotypic spectrum of AOA2, reporting a novel likely pathogenic SETX mutation (c.6208+2dupT) and highlighting an early psychiatric involvement in AOA2, suggesting the need for psychiatric assessment in these neurologic patients.

Identifiants

pubmed: 39294407
doi: 10.1007/s10072-024-07761-9
pii: 10.1007/s10072-024-07761-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Fondazione Società Italiana di Neurologia.

Références

Anheim M, Monga B, Fleury M, Charles P, Barbot C, Salih M, Delaunoy JP, Fritsch M, Arning L, Synofzik M, Schöls L, Sequeiros J, Goizet C, Marelli C, Le Ber I, Koht J, Gazulla J, De Bleecker J, Mukhtar M, Drouot N, Ali-Pacha L, Benhassine T, Chbicheb M, M’Zahem A, Hamri A, Chabrol B, Pouget J, Murphy R, Watanabe M, Coutinho P, Tazir M, Durr A, Brice A, Tranchant C, Koenig M (2009) Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain 132(Pt 10):2688–2698. https://doi.org/10.1093/brain/awp211 Epub 2009 Aug 20. PMID: 19696032
doi: 10.1093/brain/awp211 pubmed: 19696032
Fogel BL, Lee JY, Perlman S (2009) Aberrant splicing of the senataxin gene in a patient with ataxia with oculomotor apraxia type 2. Cerebellum 8(4):448–453. https://doi.org/10.1007/s12311-009-0130-8 PMID: 19727998; PMCID: PMC2788137
doi: 10.1007/s12311-009-0130-8 pubmed: 19727998 pmcid: 2788137
Moreira MC, Koenig M Ataxia with Oculomotor Apraxia Type 2. 2004 Nov 15 [updated 2018 Jul 12]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews
Zwergal A, Feil K, Schniepp R, Strupp M (2020) Cerebellar Dizziness and Vertigo: Etiologies, Diagnostic Assessment, and Treatment. Semin Neurol 40(1):87–96. https://doi.org/10.1055/s-0039-3400315
doi: 10.1055/s-0039-3400315 pubmed: 31887755
Choi JY, Glasauer S, Kim JH, Zee DS, Kim JS (2018) Characteristics and mechanism of apogeotropic central positional nystagmus. Brain 141(3):762–775. https://doi.org/10.1093/brain/awx381
doi: 10.1093/brain/awx381 pubmed: 29373699
Beaudin M, Matilla-Dueñas A, Soong BW, Pedroso JL, Barsottini OG, Mitoma H, Tsuji S, Schmahmann JD, Manto M, Rouleau GA, Klein C, Dupre N (2019) The classification of autosomal recessive cerebellar ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force. Cerebellum 18(6):1098–1125. https://doi.org/10.1007/s12311-019-01052-2 PMID: 31267374; PMCID: PMC6867988
doi: 10.1007/s12311-019-01052-2 pubmed: 31267374 pmcid: 6867988
Karamazovova S, Matuskova V, Ismail Z, Vyhnalek M (2023) Neuropsychiatric symptoms in spinocerebellar ataxias and Friedreich ataxia. Neurosci Biobehav Rev 150:105205. https://doi.org/10.1016/j.neubiorev.2023.105205 Epub 2023 May 1. PMID: 37137435
doi: 10.1016/j.neubiorev.2023.105205 pubmed: 37137435
Mignarri A, Tessa A, Carluccio MA, Rufa A, Storti E, Bonelli G, Marcotulli C, Santorelli FM, Leonardi L, Casali C, Federico A, Dotti MT (2014) Cerebellum and neuropsychiatric disorders: insights from ARSACS. Neurol Sci 35(1):95–97. https://doi.org/10.1007/s10072-013-1592-5 Epub 2013 Dec 7. PMID: 24318559

Auteurs

Federica Galota (F)

Neurology Unit, Department of Biomedical, Metabolic and Neural Science, University of Modena and Reggio Emilia, Modena, Italy.

Giulia Di Rauso (G)

Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy. giulia.dirauso@ausl.re.it.

Francesca Sireci (F)

Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Andrea Castellucci (A)

Otolaryngology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Francesco Cavallieri (F)

Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Edoardo Monfrini (E)

Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.

Valentina Fioravanti (V)

Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Isabella Campanini (I)

LAM-Motion Analysis Laboratory, Neuromotor and Rehabilitation Department, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.

Andrea Merlo (A)

LAM-Motion Analysis Laboratory, Neuromotor and Rehabilitation Department, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.

Manuela Napoli (M)

Neuroradiology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Lorenzo Cavazzuti (L)

LAM-Motion Analysis Laboratory, Neuromotor and Rehabilitation Department, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.

Sara Grisanti (S)

Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Silvia Ferrari (S)

Department of Mental Health and Drug Abuse, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Alessio Di Fonzo (A)

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.

Franco Valzania (F)

Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Classifications MeSH